aligntechnology
Align Tech declares a ‘total win’ as federal circuit reverses ITC ruling
Dental devices maker Align Technology (NSDQ:ALGN) touted a Federal Circuit Court ruling issued this month, calling it a "total win for Align."
ITC delays ruling in Align Technology case against ClearCorrect
Align Technology (NSDQ:ALGN) said the International Trade Commission put off the target date for completing its review of a May 2013 decision that ClearCorrect infringed patents for Align’s Invisalign teeth-straightening technology.
What medtech companies is BlackRock buying into?
Align Technology beats The Street with tripled Q4 profits
California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.
Align Tech and execs escape finance fraud lawsuit
Elekta’s new CEO is Nokia vet | Personnel Moves
Elekta (STO:EKTA B) said it named Niklas Savander, a former Nokia executive, as its new president & CEO. Savander is succeeding Tomas Puusepp, who will keep his seat on Stockholm-based company’s board.
IT’s Savander’s 1st venture into the medical device industry. His resume includes stints at Hewlett-Packard as well as Nokia, according to a press release.
Align Technology’s Q3 earnings shatter expectations
Align Technology (NSDQ:ALGN) beat its own forecast and shattered Wall Street’s earnings expectations with its 3rd-quarter results, sending shares up more than 15% this morning ahead of the market’s open.
Dental: German court enforces Align Tech’s injunction against Ortho Caps, Rasteder KFO
Align Technology seeks cease-and-desist against ClearCorrect
After a favorable ruling for Align Technology (NSDQ:ALGN) back in May, the International Trade Commission further reviewed the company’s patent infringement case against Pakistani dental device maker ClearCorrect.
Former Abbott exec takes the helm at Creganna-Tactx Medical | Personnel Moves
Creganna-Tactx Medical CEO Helen Ryan is preparing to pass the torch after 8 years in the corner office, with Abbott (NYSE:ABT) executive Robert "Chip" Hance slated to take the helm in September.